By TOM MURPHY, Associated Press Health Writer

The fall COVID-19 vaccine season is starting slowly for Pfizer, with U.S. sales of its Comirnaty shots sinking 25% after federal regulators narrowed recommendations on who should get them.

Related Articles

Denny’s to be acquired and taken private in a deal valued at $620 million

Gaming industry could face repercussions from NBA-Mafia gambling case

Mass murderer George Banks, spared from death penalty, dies in prison 43 years after rampage

Man accused in a series of 1980s rapes in Florida is convicted in another attack

Microsoft $9.7 billion deal with IREN will give it access to Nvidia chips

Approval of updated shots also came several weeks later than usual, and Pfizer said Tuesday that hurt sales as well.

Many Americans get vaccination

See Full Page